Temitope Oloyede

Temitope Oloyede

Medical College of Wisconsin - Milwaukee / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 5467855
person_outline Temitope Oloyede's MOST POPULAR ARTICLES
1-) Impact of age on outcomes after CD19 directed CAR T cell therapy for large B cell lymphomas: real world experience from the Center for International Blood & Marrow Transplant …AS Mirza, C Hosing, FM Foss, S Kim, A Moskop, T Oloyede, S Ahmed, ...Blood 140 (Supplement 1), 4633-4635, 202282022
2-) Real World Outcomes of Older Adults and Frail Patients with Relapse/Refractory Multiple Myeloma Receiving Idecabtagene VicleucelOS Akhtar, H Hashmi, T Oloyede, R Brazauskas, M Bye, S Sidana, ...Transplantation and Cellular Therapy, Official Publication of the American …, 202412024
3-) Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on SurvivalR Shouval, C Strouse, S Kim, T Oloyede, M Pasquini, A MoskopASH Annual Meeting & Exposition - https://ash.confex.com/ash/2023/webprogram …, 202312023
4-) Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on SurvivalR Shouval, C Strouse, S Kim, T Oloyede, S Ahmed, FT Awan, ...Blood 142, 355, 202332023
5-) Identification of Pre-Treatment Clinical Risk Factors Predictive of Inferior Survival and Increased Risk of Treatment Failure in CD19 Chimeric Antigen Receptor T Cell …PR Geethakumari, K Wudhikarn, MD Jain, A Vallurupalli, S Kim, ...Transplantation and Cellular Therapy, Official Publication of the American …, 20242024